In the exhilarating journey leading up to Revance's first FDA approval for our revolutionary drug product, DAXXIFY. Working closely with teams spanning Investor Relations, Marketing, Medical Affairs, Legal, Executives, Corporate Communications, and Digital, we orchestrated a comprehensive strategy for rolling out our Day Zero approval materials. This collective effort showcased Revance's agility and innovation in responding to real-time demands, ensuring that our momentous achievement resonated across diverse audiences.